oral glp 1 GLP-1 Orforglipron Is Approved for Obesity Oral GLP-1: A Needle-Free Solution
Description
Cheng, H
Medullary thyroid cancer GLP-1RAs were associated with increased risk of medullary thyroid carcinoma in mice but not human models
The maximum approved dose of liraglutide for the treatment of obesity is 3 mg/day, whereas the maximum dose for the treatment of T2DM is 1.8 mg/day
Jall, S
Albiglutide use in patients with HFrEF and diabetes was well tolerated, with subjects mainly reporting gastrointestinal events
Lancet 399 , 394405 (2022) R.V
